Literature DB >> 23710418

The Role of Computational Epidemiology and Risk Analysis in the Fight Against HIV/AIDS.

Berhanu Tameru1, David Nganwa, Asseged Bogale, Vinaida Robnett, Tsegaye Habtemariam.   

Abstract

Substantial progress in the understanding of HIV and CD4 cell dynamics using computational models undergirded by sound epidemiologic and mathematical principles has been achieved. The early stages of the applications of these models were based on relatively simple mathematical models that considered the body as a one-compartment system. In spite of these models attractiveness due to the experimental and/or mathematical standpoints, the underlying simplification neglected a lot of important factors affecting the population dynamics both on macro (human) and micro (cellular) population levels. This simplification also affected the kinetics linked to the immunology, infection and chemotherapy dynamics throughout the host. Epidemiologic research involves the study of a complex set of host, environmental and causative agent factors as they interact to impact health and diseases in any given population whether biotic or abiotic. This leads in generating large data sets which require the use of powerful computational methods for studying these large and complex models by means of computational epidemiologic methods. Another dimension of a great challenging problem to public health decision makers is that of emerging diseases, as they have to face and deal with a lot of uncertainty at the early stages of disease outbreaks. However, at this juncture, epidemiologic problem-solving and decision-making often proceeds in the face of uncertainties and limited information. One methodology to address these types of shortcomings is the application of risk analysis. Risk analysis is a process for decision making under uncertainty that consists of three fundamental tasks: risk management, risk assessment, and risk communication. Excitingly, the prospective role that computational models and risk analysis may possibly play in the advancement of the theoretical understanding of disease processes and the identification of specific intervention strategies holds the potential to impact and save human lives.

Entities:  

Keywords:  Computational/Mathematical epidemiology; Decision making; Risk analysis

Year:  2012        PMID: 23710418      PMCID: PMC3663484          DOI: 10.4172/2155-6113.1000e107

Source DB:  PubMed          Journal:  J AIDS Clin Res


  6 in total

1.  Modelling viral and CD4 cellular population dynamics in HIV: approaches to evaluate intervention strategies.

Authors:  T Habtemariam; P Yu; D Oryang; D Nganwa; O Ayanwale; B Tameru; H Abdelrahman; A Ahmad; V Robnett
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2001-11       Impact factor: 1.770

2.  Modelling disease outbreaks in realistic urban social networks.

Authors:  Stephen Eubank; Hasan Guclu; V S Anil Kumar; Madhav V Marathe; Aravind Srinivasan; Zoltán Toroczkai; Nan Wang
Journal:  Nature       Date:  2004-05-13       Impact factor: 49.962

3.  Computational Modelling of Intracellular Viral Kinetics and CD4+ Cellular Population Dynamics of HIV/AIDS.

Authors:  Berhanu Tameru; Tsegaye Habtemariam; David Nganwa; Lekan Ayanwale; Gemechu Beyene; Vinaida Robnett; Wanda Wilson
Journal:  Adv Syst Sci Appl       Date:  2008

4.  A quantitative risk assessment of multiple factors influencing HIV/AIDS transmission through unprotected sex among HIV-seropositive men.

Authors:  Gemechu B Gerbi; Tsegaye Habtemariam; Berhanu Tameru; David Nganwa; Vinaida Robnett
Journal:  AIDS Care       Date:  2011-09-07

5.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

6.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.